Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, Status and Forecast 2020-2026

August 2020 | 93 pages | ID: GC2F7532F694EN
QYResearch

Abstracts

Postmenopausal Vaginal Atrophy (PVA) Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Postmenopausal Vaginal Atrophy (PVA) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study

• Endoceutics
• Accord Healthcare
• Pfizer
• Novo Nordisk
• Teva Pharmaceuticals
• Shionogi & Co

Market segment by Type, the product can be split into

• Drugs Treatment
• Other Treatments

Market segment by Application, split into

• Hospital
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue
1.4 Market by Type
  1.4.1 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Drugs Treatment
  1.4.3 Other Treatments
1.5 Market by Application
  1.5.1 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Perspective (2015-2026)
2.2 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Growth Trends by Regions
  2.2.1 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Postmenopausal Vaginal Atrophy (PVA) Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Postmenopausal Vaginal Atrophy (PVA) Therapeutics Players by Market Size
  3.1.1 Global Top Postmenopausal Vaginal Atrophy (PVA) Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Concentration Ratio
  3.2.1 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue in 2019
3.3 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Key Players Head office and Area Served
3.4 Key Players Postmenopausal Vaginal Atrophy (PVA) Therapeutics Product Solution and Service
3.5 Date of Enter into Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE (2015-2026)

4.1 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Forecasted Market Size by Type (2021-2026)

5 MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2015-2020)
5.2 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size (2015-2020)
6.2 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Key Players in North America (2019-2020)
6.3 North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2015-2020)
6.4 North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size (2015-2020)
7.2 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2015-2020)
7.4 Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size (2015-2020)
8.2 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Key Players in China (2019-2020)
8.3 China Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2015-2020)
8.4 China Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size (2015-2020)
9.2 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2015-2020)
9.4 Japan Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size (2015-2020)
10.2 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size (2015-2020)
11.2 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Key Players in India (2019-2020)
11.3 India Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2015-2020)
11.4 India Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size (2015-2020)
12.2 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Endoceutics
  13.1.1 Endoceutics Company Details
  13.1.2 Endoceutics Business Overview
  13.1.3 Endoceutics Postmenopausal Vaginal Atrophy (PVA) Therapeutics Introduction
  13.1.4 Endoceutics Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2015-2020))
  13.1.5 Endoceutics Recent Development
13.2 Accord Healthcare
  13.2.1 Accord Healthcare Company Details
  13.2.2 Accord Healthcare Business Overview
  13.2.3 Accord Healthcare Postmenopausal Vaginal Atrophy (PVA) Therapeutics Introduction
  13.2.4 Accord Healthcare Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2015-2020)
  13.2.5 Accord Healthcare Recent Development
13.3 Pfizer
  13.3.1 Pfizer Company Details
  13.3.2 Pfizer Business Overview
  13.3.3 Pfizer Postmenopausal Vaginal Atrophy (PVA) Therapeutics Introduction
  13.3.4 Pfizer Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2015-2020)
  13.3.5 Pfizer Recent Development
13.4 Novo Nordisk
  13.4.1 Novo Nordisk Company Details
  13.4.2 Novo Nordisk Business Overview
  13.4.3 Novo Nordisk Postmenopausal Vaginal Atrophy (PVA) Therapeutics Introduction
  13.4.4 Novo Nordisk Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2015-2020)
  13.4.5 Novo Nordisk Recent Development
13.5 Teva Pharmaceuticals
  13.5.1 Teva Pharmaceuticals Company Details
  13.5.2 Teva Pharmaceuticals Business Overview
  13.5.3 Teva Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Therapeutics Introduction
  13.5.4 Teva Pharmaceuticals Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2015-2020)
  13.5.5 Teva Pharmaceuticals Recent Development
13.6 Shionogi & Co
  13.6.1 Shionogi & Co Company Details
  13.6.2 Shionogi & Co Business Overview
  13.6.3 Shionogi & Co Postmenopausal Vaginal Atrophy (PVA) Therapeutics Introduction
  13.6.4 Shionogi & Co Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2015-2020)
  13.6.5 Shionogi & Co Recent Development

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Postmenopausal Vaginal Atrophy (PVA) Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue
Table 3. Ranking of Global Top Postmenopausal Vaginal Atrophy (PVA) Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drugs Treatment
Table 6. Key Players of Other Treatments
Table 7. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Postmenopausal Vaginal Atrophy (PVA) Therapeutics Players
Table 18. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Postmenopausal Vaginal Atrophy (PVA) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics as of 2019)
Table 21. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Postmenopausal Vaginal Atrophy (PVA) Therapeutics Product Solution and Service
Table 24. Date of Enter into Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share (2019-2020)
Table 34. North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Type (2015-2020)
Table 36. North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share (2019-2020)
Table 40. Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share (2019-2020)
Table 46. China Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Type (2015-2020)
Table 48. China Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share (2019-2020)
Table 52. Japan Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share (2019-2020)
Table 64. India Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Type (2015-2020)
Table 66. India Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share (2019-2020)
Table 70. Central & South America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Application (2015-2020)
Table 74. Endoceutics Company Details
Table 75. Endoceutics Business Overview
Table 76. Endoceutics Product
Table 77. Endoceutics Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2015-2020) (Million US$)
Table 78. Endoceutics Recent Development
Table 79. Accord Healthcare Company Details
Table 80. Accord Healthcare Business Overview
Table 81. Accord Healthcare Product
Table 82. Accord Healthcare Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2015-2020) (Million US$)
Table 83. Accord Healthcare Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Product
Table 87. Pfizer Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2015-2020) (Million US$)
Table 88. Pfizer Recent Development
Table 89. Novo Nordisk Company Details
Table 90. Novo Nordisk Business Overview
Table 91. Novo Nordisk Product
Table 92. Novo Nordisk Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2015-2020) (Million US$)
Table 93. Novo Nordisk Recent Development
Table 94. Teva Pharmaceuticals Company Details
Table 95. Teva Pharmaceuticals Business Overview
Table 96. Teva Pharmaceuticals Product
Table 97. Teva Pharmaceuticals Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2015-2020) (Million US$)
Table 98. Teva Pharmaceuticals Recent Development
Table 99. Shionogi & Co Company Details
Table 100. Shionogi & Co Business Overview
Table 101. Shionogi & Co Product
Table 102. Shionogi & Co Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2015-2020) (Million US$)
Table 103. Shionogi & Co Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Drugs Treatment Features
Figure 3. Other Treatments Features
Figure 4. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Postmenopausal Vaginal Atrophy (PVA) Therapeutics Report Years Considered
Figure 9. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Players in 2019
Figure 14. Global Top Postmenopausal Vaginal Atrophy (PVA) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue in 2019
Figure 16. North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed